BFA
TMO icon

Bill Few Associates’s Thermo Fisher Scientific TMO Stock Holding History

Bill Few Associates’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$343K Sell
508
-10
-2% -$5.94K 0.07% 168
2026
Q2 		$260K Buy
518
+5
+1% +$2.4K 0.06% 197
2026
Q1 		$252K Sell
513
-10
-2% -$5.43K 0.06% 191
2025
Q4 		$303K Sell
523
-109
-17% -$61.6K 0.07% 156
2025
Q3 		$307K Buy
632
+44
+7% +$20.5K 0.08% 150
2025
Q2 		$238K Buy
588
+35
+6% +$14.6K 0.07% 168
2025
Q1 		$275K Hold
553
– – 0.1% 145
2024
Q4 		$288K Hold
553
– – 0.1% 141
2024
Q3 		$342K Hold
553
– – 0.12% 127
2024
Q2 		$306K Hold
553
– – 0.12% 129
2024
Q1 		$321K Hold
553
– – 0.13% 121
2023
Q4 		$294K Buy
+553
New +$268K 0.13% 122
2023
Q3 		– Sell
-384
Closed -$200K – 141
2023
Q2 		$200K Hold
384
– – 0.1% 132
2023
Q1 		$221K Hold
384
– – 0.12% 119
2022
Q4 		$211K Sell
384
-15
-4% -$7.95K 0.12% 120
2022
Q3 		$202K Hold
399
– – 0.14% 112
2022
Q2 		$217K Hold
399
– – 0.14% 110
2022
Q1 		$236K Hold
399
– – 0.13% 110
2021
Q4 		$266K Buy
+399
New +$249K 0.14% 102

Other funds holding TMO

DLA
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return
QPBE
Quintet Private Bank (Europe) Luxembourg $2.28B AUM 23.89% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $5.97B AUM 5.11% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.16B AUM 31.35% 1-Year Est. Return
AIM
Avity Investment Management Greenwich, Connecticut $1.6B AUM 32.15% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return

Bill Few Associates's TMO Position: Q3 2026 in Review

Bill Few Associates reduced its Thermo Fisher Scientific (TMO) stake by 1.9% in Q3 2026, selling an estimated $5.94K and leaving 508 shares worth $343K. The position accounts for 0.07% of the portfolio, ranked #168.

Bill Few Associates first reported a position in TMO in Q4 2021 and has held it in 19 quarters since. 134 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • Bill Few Associates held 508 shares of Thermo Fisher Scientific worth $343K as of Q3 2026.
  • Bill Few Associates sold 10 Thermo Fisher Scientific shares in Q3 2026, an estimated $5.94K.
  • Thermo Fisher Scientific made up 0.07% of Bill Few Associates's portfolio in Q3 2026, its #168 holding.
  • Bill Few Associates first reported a position in Thermo Fisher Scientific in Q4 2021 and has held it in 19 quarters since.
  • 134 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on Bill Few Associates's 13F filing for Q3 2026, filed 9 Oct 2026.